Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2008

01-06-2008 | Short Reasearch Report

Barriers to pharmaceutical care in Argentina

Authors: Sonia A. Uema, Elena M. Vega, Pedro D. Armando, Daniela Fontana

Published in: International Journal of Clinical Pharmacy | Issue 3/2008

Login to get access

Abstract

Objective To identify the perceived barriers to implementing pharmaceutical care in Argentina. Method A semi-structured questionnaire was designed to carry out a cross-sectional descriptive study. The questionnaires were distributed in different continuing professional development events for pharmacists during November–December 2005. Results Ninety completed questionnaires were collected with the following distribution: 16.7% at the national congress of hospital pharmacy, 18.9% after a conference, 64.4% during two courses related to pharmaceutical care. The surveyed pharmacists work for community pharmacies (76.7%), hospital/institutional pharmacies (20.0%) and primary care centers (2.2%). The most important barriers mentioned were lack of time, lack of specific training and lack of communication skills. Conclusion The opinions of Argentinian pharmacists from different places and professional practice settings were obtained. In all work settings, “lack of time” is the main barrier to overcome for implementing pharmaceutical care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hepler CD, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533–43.PubMed Hepler CD, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533–43.PubMed
2.
go back to reference Van Mil JWF. Atención Farmacéutica en Farmacia Comunitaria en Europa retos y barreras. Pharm Care Esp 2000;2:42–56. Van Mil JWF. Atención Farmacéutica en Farmacia Comunitaria en Europa retos y barreras. Pharm Care Esp 2000;2:42–56.
4.
go back to reference Díez Rodrigálvarez MV, Martín Sobrino N, coordinadoras. Consenso de Atención Farmacéutica. [Consensus on pharmaceutical care] Madrid: Ministerio de Sanidad y Consumo; 2001. Díez Rodrigálvarez MV, Martín Sobrino N, coordinadoras. Consenso de Atención Farmacéutica. [Consensus on pharmaceutical care] Madrid: Ministerio de Sanidad y Consumo; 2001.
5.
go back to reference Van Mil JWF. Chapter 7: Implementation barriers to pharmaceutical care. In: Van Mil JWF, editor. Pharmaceutical care: the future of the pharmacy [dissertation]. Groningen: Rijksuniversiteit Groningen; 1999. p. 139–47. Van Mil JWF. Chapter 7: Implementation barriers to pharmaceutical care. In: Van Mil JWF, editor. Pharmaceutical care: the future of the pharmacy [dissertation]. Groningen: Rijksuniversiteit Groningen; 1999. p. 139–47.
6.
go back to reference Van Mil JWF, De Boer WO, Tromp FJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract 2001;9:163–8. Van Mil JWF, De Boer WO, Tromp FJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract 2001;9:163–8.
7.
go back to reference Tulip SC, Cheung P, Campbell D, Walters P. Pharmaceutical care: cultural, practice and professional perspectives. Int J Pharm Pract 2002;10 suppl:R93. Tulip SC, Cheung P, Campbell D, Walters P. Pharmaceutical care: cultural, practice and professional perspectives. Int J Pharm Pract 2002;10 suppl:R93.
8.
go back to reference Barris D, Faus MJ. Iniciación a la metodología Dáder de seguimiento farmacoterapéutico en una farmacia comunitaria. [An iniciation in Dáder methodology in the pharmacotherapeutic monitoring in a community pharmacy] Ars Pharmaceutica 2003;44 3:225–37. Barris D, Faus MJ. Iniciación a la metodología Dáder de seguimiento farmacoterapéutico en una farmacia comunitaria. [An iniciation in Dáder methodology in the pharmacotherapeutic monitoring in a community pharmacy] Ars Pharmaceutica 2003;44 3:225–37.
9.
go back to reference Hidalgo Cabrera J, Cámara Núñez D, Baena MI, Fajardo PC, Martínez-Martínez F. Barreras para la implementación del seguimiento farmacoterapéutico en farmacias comunitarias de Granada (España). [Barriers for implementing pharmacotherapy follow-up in community pharmacies from Granada (Spain)] Seguimiento farmacoterapéutico 2005;3 3:144–9. Hidalgo Cabrera J, Cámara Núñez D, Baena MI, Fajardo PC, Martínez-Martínez F. Barreras para la implementación del seguimiento farmacoterapéutico en farmacias comunitarias de Granada (España). [Barriers for implementing pharmacotherapy follow-up in community pharmacies from Granada (Spain)] Seguimiento farmacoterapéutico 2005;3 3:144–9.
10.
go back to reference Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. Am J Health Syst Pharm 2006;63 21:2144–50.PubMedCrossRef Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. Am J Health Syst Pharm 2006;63 21:2144–50.PubMedCrossRef
Metadata
Title
Barriers to pharmaceutical care in Argentina
Authors
Sonia A. Uema
Elena M. Vega
Pedro D. Armando
Daniela Fontana
Publication date
01-06-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-007-9167-2

Other articles of this Issue 3/2008

International Journal of Clinical Pharmacy 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.